These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 37280220)
41. Testing Susceptibility of Patient-Derived Organoid Cultures to Therapies: Pharmacotyping. Burkhart RA; Baker LA; Tiriac H Methods Mol Biol; 2018; 1787():253-261. PubMed ID: 29736724 [TBL] [Abstract][Full Text] [Related]
42. A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids. Renner H; Grabos M; Becker KJ; Kagermeier TE; Wu J; Otto M; Peischard S; Zeuschner D; TsyTsyura Y; Disse P; Klingauf J; Leidel SA; Seebohm G; Schöler HR; Bruder JM Elife; 2020 Nov; 9():. PubMed ID: 33138918 [TBL] [Abstract][Full Text] [Related]
43. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing. Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390 [TBL] [Abstract][Full Text] [Related]
45. Assessment and process optimization of high throughput biofabrication of immunocompetent breast cancer model for drug screening applications. Shukla P; Bera AK; Ghosh A; Kiranmai G; Pati F Biofabrication; 2024 Jun; 16(3):. PubMed ID: 38876096 [TBL] [Abstract][Full Text] [Related]
46. High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids. Choo N; Ramm S; Luu J; Winter JM; Selth LA; Dwyer AR; Frydenberg M; Grummet J; Sandhu S; Hickey TE; Tilley WD; Taylor RA; Risbridger GP; Lawrence MG; Simpson KJ SLAS Discov; 2021 Oct; 26(9):1107-1124. PubMed ID: 34111999 [TBL] [Abstract][Full Text] [Related]
47. Three-Dimensional Organoids in Cancer Research: The Search for the Holy Grail of Preclinical Cancer Modeling. Dzobo K; Rowe A; Senthebane DA; AlMazyadi MAM; Patten V; Parker MI OMICS; 2018 Dec; 22(12):733-748. PubMed ID: 30571609 [TBL] [Abstract][Full Text] [Related]
48. Trends in Salivary Gland Tissue Engineering: From Stem Cells to Secretome and Organoid Bioprinting. Chansaenroj A; Yodmuang S; Ferreira JN Tissue Eng Part B Rev; 2021 Apr; 27(2):155-165. PubMed ID: 32723016 [TBL] [Abstract][Full Text] [Related]
49. Retinal Organoids: A Next-Generation Platform for High-Throughput Drug Discovery. Zhao H; Yan F Stem Cell Rev Rep; 2024 Feb; 20(2):495-508. PubMed ID: 38079086 [TBL] [Abstract][Full Text] [Related]
51. Rapid tissue prototyping with micro-organospheres. Wang Z; Boretto M; Millen R; Natesh N; Reckzeh ES; Hsu C; Negrete M; Yao H; Quayle W; Heaton BE; Harding AT; Bose S; Driehuis E; Beumer J; Rivera GO; van Ineveld RL; Gex D; DeVilla J; Wang D; Puschhof J; Geurts MH; Yeung A; Hamele C; Smith A; Bankaitis E; Xiang K; Ding S; Nelson D; Delubac D; Rios A; Abi-Hachem R; Jang D; Goldstein BJ; Glass C; Heaton NS; Hsu D; Clevers H; Shen X Stem Cell Reports; 2022 Sep; 17(9):1959-1975. PubMed ID: 35985334 [TBL] [Abstract][Full Text] [Related]
52. Small Joint Organoids 3D Bioprinting: Construction Strategy and Application. Zhang Y; Li G; Wang J; Zhou F; Ren X; Su J Small; 2024 Feb; 20(8):e2302506. PubMed ID: 37814373 [TBL] [Abstract][Full Text] [Related]
53. Automated high-speed 3D imaging of organoid cultures with multi-scale phenotypic quantification. Beghin A; Grenci G; Sahni G; Guo S; Rajendiran H; Delaire T; Mohamad Raffi SB; Blanc D; de Mets R; Ong HT; Galindo X; Monet A; Acharya V; Racine V; Levet F; Galland R; Sibarita JB; Viasnoff V Nat Methods; 2022 Jul; 19(7):881-892. PubMed ID: 35697835 [TBL] [Abstract][Full Text] [Related]
54. Establishment of patient-derived cancer organoids for drug-screening applications. Driehuis E; Kretzschmar K; Clevers H Nat Protoc; 2020 Oct; 15(10):3380-3409. PubMed ID: 32929210 [TBL] [Abstract][Full Text] [Related]
55. OrganoIDNet: a deep learning tool for identification of therapeutic effects in PDAC organoid-PBMC co-cultures from time-resolved imaging data. Ferreira N; Kulkarni A; Agorku D; Midelashvili T; Hardt O; Legler TJ; Ströbel P; Conradi LC; Alves F; Ramos-Gomes F; Markus MA Cell Oncol (Dordr); 2024 May; ():. PubMed ID: 38805131 [TBL] [Abstract][Full Text] [Related]
56. 3D Modeling of Epithelial Tumors-The Synergy between Materials Engineering, 3D Bioprinting, High-Content Imaging, and Nanotechnology. Trivedi P; Liu R; Bi H; Xu C; Rosenholm JM; Åkerfelt M Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207601 [TBL] [Abstract][Full Text] [Related]
57. Single-Cell Transcriptomics Reveals Heterogeneity and Drug Response of Human Colorectal Cancer Organoids. Chen KY; Srinivasan T; Lin C; Tung KL; Gao Z; Hsu DS; Lipkin SM; Shen X Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():2378-2381. PubMed ID: 30440885 [TBL] [Abstract][Full Text] [Related]
58. Bovine colon organoids: From 3D bioprinting to cryopreserved multi-well screening platforms. Töpfer E; Pasotti A; Telopoulou A; Italiani P; Boraschi D; Ewart MA; Wilde C Toxicol In Vitro; 2019 Dec; 61():104606. PubMed ID: 31344400 [TBL] [Abstract][Full Text] [Related]
59. 3D bioprinted vascularized lung cancer organoid models with underlying disease capable of more precise drug evaluation. Choi YM; Lee H; Ann M; Song M; Rheey J; Jang J Biofabrication; 2023 Jun; 15(3):. PubMed ID: 37236168 [TBL] [Abstract][Full Text] [Related]
60. In Situ Expansion, Differentiation, and Electromechanical Coupling of Human Cardiac Muscle in a 3D Bioprinted, Chambered Organoid. Kupfer ME; Lin WH; Ravikumar V; Qiu K; Wang L; Gao L; Bhuiyan DB; Lenz M; Ai J; Mahutga RR; Townsend D; Zhang J; McAlpine MC; Tolkacheva EG; Ogle BM Circ Res; 2020 Jul; 127(2):207-224. PubMed ID: 32228120 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]